Acorah Software Products - Accounts Production 16.7.461 false true 31 March 2024 1 January 2023 false 1 April 2024 31 March 2025 31 March 2025 08329418 Dr Kim Booysen iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08329418 2024-03-31 08329418 2025-03-31 08329418 2024-04-01 2025-03-31 08329418 frs-core:CurrentFinancialInstruments 2025-03-31 08329418 frs-core:FurnitureFittings 2025-03-31 08329418 frs-core:FurnitureFittings 2024-04-01 2025-03-31 08329418 frs-core:FurnitureFittings 2024-03-31 08329418 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2025-03-31 08329418 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2024-04-01 2025-03-31 08329418 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2024-03-31 08329418 frs-core:PlantMachinery 2025-03-31 08329418 frs-core:PlantMachinery 2024-04-01 2025-03-31 08329418 frs-core:PlantMachinery 2024-03-31 08329418 frs-core:ShareCapital 2025-03-31 08329418 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 08329418 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 08329418 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 08329418 frs-bus:SmallEntities 2024-04-01 2025-03-31 08329418 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 08329418 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 08329418 frs-core:ListedExchangeTraded 2025-03-31 08329418 frs-core:ListedExchangeTraded 2024-03-31 08329418 frs-core:CostValuation frs-core:ListedExchangeTraded 2024-03-31 08329418 frs-core:AdditionsToInvestments frs-core:ListedExchangeTraded 2025-03-31 08329418 frs-core:RevaluationsIncreaseDecreaseInInvestments frs-core:ListedExchangeTraded 2025-03-31 08329418 frs-core:CostValuation frs-core:ListedExchangeTraded 2025-03-31 08329418 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2024-03-31 08329418 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2025-03-31 08329418 frs-bus:Director1 2024-04-01 2025-03-31 08329418 frs-countries:EnglandWales 2024-04-01 2025-03-31 08329418 2022-12-31 08329418 2024-03-31 08329418 2023-01-01 2024-03-31 08329418 frs-core:CurrentFinancialInstruments 2024-03-31 08329418 frs-core:ShareCapital 2024-03-31 08329418 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: 08329418
KB Healthcare Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2025
Anumerate Limited
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 08329418
31 March 2025 31 March 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 26,824 32,323
Investments 5 46,159 36,118
72,983 68,441
CURRENT ASSETS
Debtors 6 2,010 2,442
Cash at bank and in hand 42,700 52,256
44,710 54,698
Creditors: Amounts Falling Due Within One Year 7 (40,116 ) (51,571 )
NET CURRENT ASSETS (LIABILITIES) 4,594 3,127
TOTAL ASSETS LESS CURRENT LIABILITIES 77,577 71,568
NET ASSETS 77,577 71,568
CAPITAL AND RESERVES
Called up share capital 8 2 2
Profit and Loss Account 77,575 71,566
SHAREHOLDERS' FUNDS 77,577 71,568
Page 1
Page 2
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr Kim Booysen
Director
30/11/2025
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
KB Healthcare Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 08329418 . The registered office is 13 Ethelbert Road, Bromley, BR1 1JA.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 25% Reducing Balance
Fixtures & Fittings 25% Straight Line
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 1)
2 1
Page 3
Page 4
4. Tangible Assets
Land & Property
Leasehold Plant & Machinery Fixtures & Fittings Total
£ £ £ £
Cost
As at 1 April 2024 11,342 26,566 2,030 39,938
As at 31 March 2025 11,342 26,566 2,030 39,938
Depreciation
As at 1 April 2024 - 6,600 1,015 7,615
Provided during the period - 4,991 508 5,499
As at 31 March 2025 - 11,591 1,523 13,114
Net Book Value
As at 31 March 2025 11,342 14,975 507 26,824
As at 1 April 2024 11,342 19,966 1,015 32,323
5. Investments
Listed
£
Cost or Valuation
As at 1 April 2024 36,118
Additions 12,227
Revaluations (2,186 )
As at 31 March 2025 46,159
Provision
As at 1 April 2024 -
As at 31 March 2025 -
Net Book Value
As at 31 March 2025 46,159
As at 1 April 2024 36,118
Investments are classified as current asset investments and are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.
6. Debtors
31 March 2025 31 March 2024
£ £
Due within one year
Trade debtors 490 907
Other debtors 1,520 1,535
2,010 2,442
Page 4
Page 5
7. Creditors: Amounts Falling Due Within One Year
31 March 2025 31 March 2024
£ £
Trade creditors (1 ) 1,000
Bank loans and overdrafts 11,749 8,814
Taxation and social security 28,368 41,757
40,116 51,571
8. Share Capital
31 March 2025 31 March 2024
£ £
Allotted, Called up and fully paid 2 2
Page 5